Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy

Antiviral Therapy

Volumn 10, Issue SUPPL. 2, 2005, Pages

  Mallon, Patrick W G ^a,b,c   Sedwell, Rebecca ^a,c   Unemori, Patrick ^a,c   Kelleher, Anthony ^a,b,c   Cooper, David A ^a,b,c   Carr, Andrew ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c Immunology Department   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA ACTIN; RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

CONFERENCE PAPER; DRUG MECHANISM; GENE EXPRESSION; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LIPOATROPHY; METHODOLOGY; PRIORITY JOURNAL; RNA EXTRACTION; SAMPLING;

CCAAT-ENHANCER-BINDING PROTEINS; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; POLYMERASE CHAIN REACTION; RESEARCH DESIGN; RNA; SPECIMEN HANDLING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS;

EID: 24044451251     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ & Cheng AK; 903 Study Group. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. Journal of the American Medical Association 2004; 292:191-201.
2. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ & Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12:F51-F58.
3. Mallon PWG, Miller J, Cooper D & Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1 infected men starting therapy. AIDS 2003; 17:971-979.
4. Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J & Cooper DA; Mitochondrial Toxicity Study Group. Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. AIDS 2004; 18:1029-1036.
5. Liang J-S, Distler O, Cooper DA, Jamil H, Deckelbaum RJ, Ginsberg HN & Sturley SL. HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidaemia. Nature Medicine 2001; 7:1-5.
6. Caron M, Auclair M, Vigouroux C, Glorian M, Forest C & Capeau J. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localisation, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 2001; 50:1378-1388.
7. Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, Chisholm D, Samaras K, Emery S, Kelleher A, Cooper DA & Carr A; SAMA Investigators. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. Journal of Infectious Diseases 2005; 191:1686-1696.
8. Brinkman K, Smeitink JA, Romijn HA & Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-related lipodystrophy. Lancet 1999; 354:1112-1115.
9. Lewis W & Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nature Medicine 1995; 1:417-422.
10. Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B & Mallal S. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 2003; 17:1329-1338.
11. Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S & Shiramizu B. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV infected individuals with peripheral lipoatrophy. AIDS 2001; 15:1801-1809.
12. Mallon PWG, Cooper DA & Carr A. HIV-associated lipodystrophy. HIV Medicine 2001; 2:166-173.
13. Kannisto K, Sutinen J, Korsheninnikova E, Fisher RM, Ehrenborg E, Gertow K, Virkamaki A, Nyman T, Vidal H, Hamsten A & Yki-Jarvinen H. Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 2003; 17:1753-1762.
14. Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, Euboinski J, Laville M, Maachi M, Girard PM, Rozenbaum W, Levan P & Capeau J. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002; 359:1026-1031.
15. TRIzol reagent Product Information. Invitrogen Life Technologies, Carlsbad, CA, USA.
16. Bustin SA & Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. Journal of Biomolecular Techniques 2004; 15:155-166.
17. Liu YM, Lacorte JM, Viguerie N, Poitou C, Pelloux V, Guy-Grand B, Coussieu C, Langin D, Basdevant A & Clement K. Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding. Journal of Clinical Endocrinology & Metabolism 2003; 88:5881-5886.
18. Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L & Stewart PM. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. Journal of Clinical Endocrinology & Metabolism 2004; 89:2711-2716.
19. Tükkainen M, Hakkinen AM, Korsheninnikova E, Nyman T, Makimattila S & Yki-Jarvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004; 53:2169-2176.
20. Marchlewska A, Stenvinkel P, Lindholm B, Danielsson A, Pecoits-Filho R, Lonnqvist F, Schalling M, Heimburger O & Nordfors L. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney International 2004; 66:46-50.
21. Otake K, Omoto S, Yamamoto T, Okuyama H, Okada H, Okada N, Kawai M, Saksena NK & Fujii YR. HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors. AIDS 2004; 18:189-198.
22. Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G & Tarnopolsky MA. Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiological Genomics 2004; 18:226-231.
23. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Bustin SA & Orlando C. Quantitative real-time reverse transcription polymerase cnain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Analytical Biochemistry 2002; 309:293-300.
24. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F. Accurate normalization or real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002; 3:research0034.1-0034.11.
25. Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamaki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A & Yki-Jarvinen H. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. American Journal of Physiology, Endocrinology & Metabolism 2004; 286:E941-E949.